Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III)
- PMID: 198168
- DOI: 10.1111/j.1399-0004.1977.tb00917.x
Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III)
Abstract
The apoprotein composition of the main lipoprotein fractions (VLDL, LDL-1, LDL-2 and HDL) was studied initially in 15 patients with Broad-beta disease. Analytical isoelectric focusing of urea-soluble apo-VLDL and apo LSL-1 demonstrated a variant pattern of the polymorphic Apoprotein E with a deficient Apo E-III band in all patients. The Apo E-III deficiency pattern was seen in only six out of 304 hyperlipidaemic controls. These six Apo E-III deficient controls had characteristic signs of Broad-beta disease, and thus represented patients not previously recognized as having the disorder. The Apo E focusing patterns were constant on repeated examinations and were stable under different metabolic conditions. The data show that Apo E-III deficiency in VLDL is a specific qualitative marker for Broad-beta disease, allowing an unequivocal diagnosis that had not been possible previously. Indirect evidence suggests that Apo E-III deficiency is the basic lipoprotein abnormality underlying the familial dyslipoproteinaemia.
Similar articles
-
Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.Scand J Clin Lab Invest. 1975 Nov;35(7):655-60. Scand J Clin Lab Invest. 1975. PMID: 174185
-
Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.Eur J Clin Invest. 1975 Jul 29;5(4):359-64. doi: 10.1111/j.1365-2362.1975.tb00465.x. Eur J Clin Invest. 1975. PMID: 170119
-
Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia.Clin Chim Acta. 1977 Mar 15;75(3):487-90. doi: 10.1016/0009-8981(77)90370-9. Clin Chim Acta. 1977. PMID: 192494
-
Recent progress in the development of radioimmunoassays for human serum lipoproteins.Ann Clin Lab Sci. 1978 Mar-Apr;8(2):142-54. Ann Clin Lab Sci. 1978. PMID: 205163 Review.
-
Type II hyperlipoproteinaemia.Clin Endocrinol Metab. 1973 Mar;2(1):81-109. doi: 10.1016/s0300-595x(73)80028-3. Clin Endocrinol Metab. 1973. PMID: 4361963 Review. No abstract available.
Cited by
-
Human apolipoprotein E isoprotein subclasses are genetically determined.Am J Hum Genet. 1981 Jan;33(1):11-24. Am J Hum Genet. 1981. PMID: 7468588 Free PMC article.
-
Apolipoprotein polymorphism and multifactorial hyperlipidaemia.J Inherit Metab Dis. 1988;11 Suppl 1:74-86. doi: 10.1007/BF01800572. J Inherit Metab Dis. 1988. PMID: 3141688 Review.
-
Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.Hum Genet. 1982;60(4):344-51. doi: 10.1007/BF00569216. Hum Genet. 1982. PMID: 7106770 No abstract available.
-
Genetics of the apolipoprotein E system in man.Am J Hum Genet. 1980 May;32(3):339-47. Am J Hum Genet. 1980. PMID: 7386461 Free PMC article.
-
Apolipoprotein E phenotypes and hyperlipidemia.Hum Genet. 1984;65(3):232-6. doi: 10.1007/BF00286508. Hum Genet. 1984. PMID: 6698547
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources